These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration]. Valiente A, Outeriño J, Martín Calderín F, Benítez J. Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668 [Abstract] [Full Text] [Related]
3. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. González FA, Villegas A, Ferro MT, San Román C, Sáez I, López M, del Potro E, Alvarez A, Martínez R, Díaz Madiavilla J. Med Clin (Barc); 1993 Oct 30; 101(14):521-4. PubMed ID: 8231395 [Abstract] [Full Text] [Related]
4. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation]. Xue YQ. Zhonghua Yi Xue Za Zhi; 1993 Apr 30; 73(4):209-12, 252-3. PubMed ID: 8395313 [Abstract] [Full Text] [Related]
5. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia]. Chen S. Zhonghua Yi Xue Za Zhi; 1991 Aug 30; 71(8):425-7, 30. PubMed ID: 1660759 [Abstract] [Full Text] [Related]
6. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11. Sessarego M, Fugazza G, Bruzzone R, Ballestrero A, Miglino M, Bacigalupo A. Haematologica; 2000 Jan 30; 85(1):35-9. PubMed ID: 10629589 [Abstract] [Full Text] [Related]
7. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia. Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ, Beran M. Cancer; 2002 Oct 15; 95(8):1673-84. PubMed ID: 12365015 [Abstract] [Full Text] [Related]
9. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia. Dreazen O, Klisak I, Rassool F, Goldman JM, Sparkes RS, Gale RP. Oncogene Res; 1988 Oct 15; 2(2):167-75. PubMed ID: 3217110 [Abstract] [Full Text] [Related]
17. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders? Roumier C, Daudignon A, Soenen V, Dupriez B, Wetterwald M, Lai JL, Cosson A, Fenaux P, Preudhomme C. Haematologica; 1999 Dec 15; 84(12):1075-80. PubMed ID: 10586207 [Abstract] [Full Text] [Related]
18. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias. Aurich J, Duchayne E, Huguet-Rigal F, Bauduer F, Navarro M, Perel Y, Pris J, Caballin MR, Dastugue N. Hematol Cell Ther; 1998 Aug 15; 40(4):149-58. PubMed ID: 9766919 [Abstract] [Full Text] [Related]
19. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients. Yazici H, Sengün Z, Aktan M, Aktuglu G, Uskent N, Dalay N. J Exp Clin Cancer Res; 1997 Mar 15; 16(1):105-9. PubMed ID: 9148870 [Abstract] [Full Text] [Related]